LINC01806: A Drug Target / Disease Biomarker (G100996579)

Target Name: LINC01806

NCBI ID: G100996579

LINC01806

Other Name(s): Long intergenic non-protein coding RNA 1806, transcript variant 1 | long intergenic non-protein coding RNA 1806

LINC01806: A Drug Target / Disease Biomarker

LINC01806 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key regulator of cell adhesion and survival, and is involved in the development and maintenance of tissues such as the placenta and the blood vessels.

LINC01806 is a transmembrane protein that is expressed in the brain, heart, and kidneys. It is a key regulator of cell adhesion and survival, and is involved in the development and maintenance of tissues such as the placenta and the blood vessels. It is composed of four transmembrane domains and a cytoplasmic tail.

One of the most significant functions of LINC01806 is its role in cell adhesion. This protein helps to regulate the formation and maintenance of tight junctions, which are specialized barriers that separate cells from the surrounding tissue.tight junctions are critical for ensuring the integrity of tissues and are involved in various physiological processes, including the regulation of ion and solute transport, and the prevention of excessive water and ion movement into or out of cells.

In addition to its role in cell adhesion, LINC01806 is also involved in the regulation of cell survival. This protein helps to prevent the apoptosis, or programmed cell death, that can occur in response to various stressors, such as UV radiation, chemical insults, or mechanical stress. By preventing apoptosis, LINC01806 helps to ensure the longevity of cells and is involved in the development and maintenance of tissues.

LINC01806 is also involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed in response to increased blood flow or oxygen demand. This protein helps to control the formation of new blood vessels and is involved in the regulation of blood vessel growth, branching, and diameter.

In conclusion, LINC01806 is a protein that is involved in a variety of important physiological processes in the body. Its role in cell adhesion, survival, and angiogenesis makes it an attractive drug target and a potential biomarker for a variety of diseases. Further research is needed to fully understand the functions of this protein and to develop effective treatments for those with disruptions in its regulation.

Protein Name: Long Intergenic Non-protein Coding RNA 1806

The "LINC01806 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01806 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets